0 التعليقات
0 المشاركات
161 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Trastuzumab-Botidotin: Advancing HER2-targeted therapy into a new era of dual-epitope synergistic effectsAs precision oncology continues to evolve, HER2 (human epidermal growth factor receptor 2) has become one of the most established and clinically valuable therapeutic targets across a wide range of solid tumors. With growing insight into tumor heterogeneity and resistance mechanisms, the limitations of single-target, single-mechanism therapies are increasingly apparent. Improving efficacy while...0 التعليقات 0 المشاركات 953 مشاهدة 0 معاينة
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 التعليقات 0 المشاركات 4كيلو بايت مشاهدة 0 معاينة
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 التعليقات 0 المشاركات 308 مشاهدة 0 معاينة
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 التعليقات 0 المشاركات 321 مشاهدة 0 معاينة
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 التعليقات 0 المشاركات 321 مشاهدة 0 معاينة
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة1
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Global High Potent Pharmaceuticals Product Market Outlook: Growth Trends, Forecasts & Strategic AnalysisHigh Potent Pharmaceutical Products refer to drugs with extremely high pharmacological potency that can affect the body even at small concentrations. Because of their strong biological effects, they must be manufactured under controlled environments. These products are widely used in cancer treatment and hormone-based therapies. High Potent Pharmaceuticals Product Market Analysis and...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Global Neurofibromatosis Drugs Market Forecast Report: Trends, Analysis, and Growth PotentialNeurofibromatosis drugs include targeted treatments designed to inhibit tumor growth and reduce complications. These therapies are part of a multidisciplinary approach to disease management. Neurofibromatosis Drugs Market Size and Growth Outlook (2026–2034) The global Neurofibromatosis Drugs Market size is projected to reach US$ 12.34 billion by 2034 from US$ 3.45 billion...0 التعليقات 0 المشاركات 845 مشاهدة 0 معاينة
-
In-Depth Growth Drivers and Strategic Trends in the Breast Cancer Therapeutics Market Developments and Forecast by 2030The Breast Cancer Therapeutics Market is witnessing substantial growth as healthcare systems worldwide intensify efforts to combat one of the most prevalent cancers affecting women. Driven by rising incidence rates, improved diagnostic capabilities, and a strong pipeline of innovative therapies, the market is positioned for remarkable expansion over the next decade. According to industry...0 التعليقات 0 المشاركات 748 مشاهدة 0 معاينة
-
Market Intelligence: Basal Cell Carcinoma Treatment Trends and DriversHealthcare infrastructure improvements are enhancing access to skin cancer treatments.Specialized dermatology centers are expanding globally.This accessibility is contributing to increased treatment adoption The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة1
-
Market Outlook 2025–2031: Future of Sarcoma Drug DevelopmentOrphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 التعليقات 0 المشاركات 4كيلو بايت مشاهدة 0 معاينة1
الصفحات المعززة